Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
NeuCA15-3 Test
NeuCA125 Test
EXO-Ovarian Cancer Test
Exosome Therapeutics
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
3-Sep-2024
Mary Harney - Non-Executive Director
20-Aug-2024
NEURO-NET validated in Parkinson's
19-Aug-2024
EGM and Webinar Broadcast
30-Jul-2024
Quarterly Activities Report and Appendix 4C - June 2024
19-Jul-2024
Notice of Extraordinary General Meeting
5-Jul-2024
Successful completion of Share Purchase Plan
19-Jun-2024
Target Market Determination (not ASX released)
19-Jun-2024
INOVIQ lodges SPP and Options Prospectus
12-Jun-2024
Investor Presentation
12-Jun-2024
INOVIQ isolates brain-derived exosomes in Alzheimer's
Previous
1
2
3
4
Next
